Ubs Group Ag Senti Biosciences, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.36 - $0.66 $263 - $483	732 New	732 $0
Q3 2023 Nov 09, 2023	BUY	$0.41 - $0.99 $82 - $199	202 New	202 $0
Q1 2023 May 12, 2023	SELL	$1.15 - $2.06 $481 - $863	-419 Reduced 7.2%	5,398 $6,000
Q4 2022 Feb 08, 2023	SELL	$1.25 - $65.2 $4,787 - $249,716	-3,830 Reduced 39.7%	5,817 $8,000
Q3 2022 Nov 10, 2022	BUY	$1.33 - $21.7 $12,817 - $209,122	9,637 Added 96370.0%	9,647 $21,000
Q2 2022 Aug 10, 2022	BUY	$1.97 - $10.0 $19 - $100	10 New	10 $0

342K

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $172M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.